Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TAP Block vs Wound Infiltration for Postoperative Analgesia in Inguinal Hernia Repair
NCT07913633Completed
- Sponsor
- Mayo Clinic
- Start
- Jan 2026
- Primary completion
- Jun 2026
- Countries
- 1
01
Overview
Randomised trial of bupivacaine hydrochloride 0.75% injection in postoperative pain (2 arms), sponsored by Mayo Clinic. Primary endpoint: Mean Pain Score at 4 hours. Started Jan 2026; status: completed.
02
Drugs
bupivacaine hydrochloride 0.75% injection
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT07913633.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07913633.